Listed

Ocular Therapeutix, Inc

OCULNasdaqCIK 1393434HealthcareFiscal year ends Dec 31

Reports and events: 233 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ocular Therapeutix, Inc, Reports and events
FiledFormWhat it isAccession number
2023-11-0716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-115223
2023-10-0409:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-106651
2023-10-0316:15 ET8-K8.01 Other events0001104659-23-106399
2023-09-1307:07 ET8-K8.01 Other events0001104659-23-100234
2023-08-0716:09 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-013591
2023-08-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-088335
2023-07-1208:31 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-080180
2023-07-0716:28 ET8-K1.01 Entry into a material agreement0001104659-23-079140
2023-06-1616:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-23-072258
2023-06-1206:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-070107
2023-05-0816:06 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-008510
2023-05-0816:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-057139
2023-05-0116:05 ETDEF 14AProxy statementPeriod 2023-06-140001558370-23-007482
2023-04-0616:24 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-23-042710
2023-03-0616:08 ET10-KAnnual reportPeriod 2022-12-310001558370-23-002908
2023-03-0616:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-028993
2023-01-0608:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-001710
2022-11-0716:07 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016610
2022-11-0716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-115406
2022-09-3021:33 ET8-K7.01 Regulation FD disclosure0001104659-22-104258
2022-08-0816:14 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-012623
2022-08-0816:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-087227
2022-06-1708:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-22-072151
2022-06-0807:51 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-069168
2022-05-0916:07 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-007812
2022-05-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-057490
2022-05-0216:05 ETDEF 14AProxy statementPeriod 2022-06-160001558370-22-006631
2022-02-2816:28 ET10-KAnnual reportPeriod 2021-12-310001558370-22-002363
2022-02-2816:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-028082
2022-02-0717:01 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-012842
2021-11-0816:07 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-015029
2021-11-0816:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-135632
2021-09-2208:15 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-118126
2021-08-0916:48 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-102200
2021-08-0916:07 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-010967
2021-08-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-102117
2021-07-2216:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-094929
2021-06-2216:14 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-21-084122
2021-06-0416:34 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-21-077080
2021-05-0516:08 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-005914
2021-05-0516:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-061700
2021-04-2916:15 ETDEF 14AProxy statementPeriod 2021-06-180001558370-21-005257
2021-04-2906:31 ET8-K2.02 Results of operations0001104659-21-056872
2021-04-2716:51 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-055663
2021-03-1116:06 ET10-KAnnual reportPeriod 2020-12-310001558370-21-002813
2021-03-1116:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-034990
2021-02-1216:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-021935
2021-01-2008:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-005650
2021-01-1119:23 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-002580
2020-12-1806:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-137117

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 00:35 ET. Listed shows no prices and gives no investment advice.